UHS Completes Phase-III Clinical Trials of Chinese COVID-19 Vaccine

University of Health Sciences (UHS) has successfully completed the phase-III clinical trials of a Chinese vaccine. More than 3,000 volunteers from all over Pakistan had participated in these trials.

A formal ceremony to celebrate the successful conclusion of the vaccine trials was held at UHS which was attended by Vice-Chancellor UHS, Prof. Javed Akram, and Chinese healthcare experts. Prof. Javed Akram congratulated the Chinese delegation on achieving the milestone.


ALSO READ

Virat Kohli Reveals How Shahid Afridi Almost Ended His Career


While speaking with media outlets after the ceremony, Prof. Akram noted that the vaccine has triggered the intended immune response among the participants, adding that detailed findings of the clinical trials will be published soon.

The candidate vaccine, known as Ad5-nCoV, has been developed by CanSinoBIO, a Chinese vaccine manufacturer, in collaboration with the Beijing Institute of Biotechnology.


ALSO READ

Study Reveals Alarming Levels of Violence Against Healthcare Workers in COVID-19 Pandemic


Earlier this month, Governor Punjab, Chaudhry Muhammad Sarwar, along with his wife and staff members of the Governor House Lahore had received the shots of the CanSinoBIO vaccine at the UHS.

Follow ProPakistani on Google News & scroll through your favourite content faster!

Support independent journalism

If you want to join us in our mission to share independent, global journalism to the world, we’d love to have you on our side. If you can, please support us on a monthly basis. It takes less than a minute to set up, and you can rest assured that you’re making a big impact every single month in support of open, independent journalism. Thank you.



Get Alerts

Follow ProPakistani to get latest news and updates.


ProPakistani Community

Join the groups below to get latest news and updates.



>